Patents by Inventor Miha Tomaz Jaklic

Miha Tomaz Jaklic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Compositions Comprising Canagliflozin
    Publication number: 20170258761
    Abstract: The present invention belongs to the field of pharmaceutical industry and relates to a dry pharmaceutical composition comprising Canagliflozin, as well as to a process for preparing the same. Such dry pharmaceutical composition is useful as a medicament, especially for the normalization of plasma glucose levels.
    Type: Application
    Filed: August 28, 2015
    Publication date: September 14, 2017
    Applicant: Sandoz AG
    Inventors: Mateja Burjak, Tanja Rozman Peterka, Bostjan Petek, Bostjan Markun, Katja Berginc, Miha Tomaz Jaklic, Rok Grahek, Zoran Ham
  • DULOXETIN COMPOSITION
    Publication number: 20110008439
    Abstract: The present invention relates to a stable pharmaceutical pellet composition comprising duloxetine or a pharmaceutically acceptable salt thereof and a method for making such composition. In particular, the composition comprises duloxetine hydrochloride and a separating layer comprising a water soluble inorganic salt.
    Type: Application
    Filed: December 21, 2007
    Publication date: January 13, 2011
    Applicant: LEK Pharmaceuticals d.d.
    Inventors: Miha Tomaz Jaklic, Rok Jurecic
  • Process For Preparing Solid Dosage Forms of Rosiglitazone Maleate
    Publication number: 20100120868
    Abstract: The invention relates to a process for preparing a solid pharmaceutical composition rosiglitazone maleate, comprising the step of adsorption of rosiglitazone maleate onto carrier particles (C) during a dry mixing process.
    Type: Application
    Filed: November 6, 2009
    Publication date: May 13, 2010
    Inventors: Tijana Stanic Ljubin, Sebastjan Reven, Miha Tomaz Jaklic, Peter Svete
  • Pharmaceutical composition
    Publication number: 20090093499
    Abstract: A chemically stable formulation of (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically-acceptable salt thereof for oral use, such as tablets, capsules, powders, granules has been developed using the substances which stabilize against formation of degradation products: lactone and oxidation product.
    Type: Application
    Filed: December 18, 2006
    Publication date: April 9, 2009
    Applicant: LEK PHARMACEUTICALS D.D.
    Inventors: Miha Tomaz Jaklic, Klemen Naversnik